EISAI CO., LTD. (ESALF)
Clinical trial NCT03331250 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-02-01 → 2023-05-23 3. primary completion date: 2023-07-21 → 2022-03-31
Clinical trial NCT03331250 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-02-01 → 2023-05-23 3. primary completion date: 2023-07-21 → 2022-03-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical